688366 昊海生科
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入571,435-7.62%2,472,9982,697,6582,654,0392,130,276
减:营业总成本490,120-4.09%2,136,2742,243,9492,187,7431,864,420
    其中:营业成本192,4692.09%738,762812,626782,849660,761
               财务费用(5,653)-44.62%(60,671)(48,703)(62,217)(74,097)
               资产减值损失(2,226)-66.24%(198,518)(32,238)(6,741)(54,239)
公允价值变动收益391231.77%31,06225,9152,296(7,784)
投资收益(279)244.06%4,5421,0021,1425,808
    其中:对联营企业和合营企业的投资收益(279)144.43%109864563,505
营业利润96,358-7.18%220,210494,761507,413234,586
利润总额96,260-6.84%239,245466,145508,261235,727
减:所得税费用24,60026.05%30,92489,90295,99145,395
净利润71,660-14.50%208,321376,243412,269190,332
减:非控股权益(1,899)-70.79%(42,687)(44,204)(3,852)9,862
股东净利润73,559-18.55%251,009420,447416,121180,470

市场价值指针
每股收益 (元) *0.320-17.95%1.0801.8001.7501.040
每股派息 (元) *----1.0001.0001.0000.400
每股净资产 (元) *23.668-2.64%23.51623.90832.94931.670
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容